Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
Treatment of MuSK-Associated Myasthenia Gravis
2014
An update on LDL apheresis for nephrotic syndrome
2018
Incorporation of low-density lipoprotein apheresis into the treatment program of patients with severe hypercholesterolemia
2000
Advanced oxidation protein products as a novel marker of oxidative stress in uremia
1996 Standout
Low‐density Lipoprotein Apheresis in the Treatment of Peripheral Arterial Disease
2003
Successful removal of pathogenic autoantibodies in pemphigus by immunoadsorption with a tryptophan-linked polyvinylalcohol adsorber
2003
Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide
2014 Standout
Dextran‐sulfate‐adsorption of atherosclerotic lipoproteins from whole blood or separated plasma for lipid‐apheresis—Comparison of performance characteristics with DALI and lipidfiltration
2007
Changes of Hemorheological and Biochemical Parameters after Plasma Perfusion Using a Tryptophan-Polyvinyl Alcohol Adsorber Leading to Clinical Improvement in Patients Suffering from Maculopathy
1998
Efficacy, safety, and tolerability of long-term lipoprotein apheresis in patients with LDL- or Lp(a) hyperlipoproteinemia: Findings gathered from more than 36,000 treatments at one center in Germany
2015
Moringa oleifera: a food plant with multiple medicinal uses
2006 Standout
Immunoadsorption in Systemic Lupus Erythematosus: Different Techniques and their Current Role in Medical Therapy
2003
Low‐Density Lipoprotein Apheresis and Changes in Plasma Components
2001
Efficacy and safety of DALI LDL‐apheresis at high blood flow rates: A prospective multicenter study
2003
Rheopheresis: Rheologic, Functional, and Structural Aspects
2000
A proposed nomenclature and diagnostic criteria for protein–energy wasting in acute and chronic kidney disease
2007 Standout
Vitamin D Deficiency
2007 Standout
Hydrogel: Preparation, characterization, and applications: A review
2013 Standout
Antioxidant Activity and Total Phenolic Content of Moringa oleifera Leaves in Two Stages of Maturity
2009 Standout
Chronic kidney disease alters intestinal microbial flora
2012 Standout
In face of the increasing efficacy of lipid-lowering therapy, is there still a place for LDL-apheresis?
2004
Efficacy of Different Low‐Density Lipoprotein Apheresis Methods
2000
Auxin: Regulation, Action, and Interaction
2005 Standout
From Membrane Differential Filtration to Lipidfiltration: Technological Progress in Low‐density Lipoprotein Apheresis
2003
Acute Renal Failure
1996 Standout
Lipidfiltration––safe and effective methodology to perform lipid-apheresis
2004
Lipoprotein-apheresis: Austrian consensus on indication and performance of treatment
2015
The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia
2002
Recent advances in therapeutic apheresis
2003
Low‐density Lipoprotein Apheresis: An Overview
2003
Recommendations for the use of LDL apheresis
2008
Low‐Density Lipoprotein Apheresis: Clinical Results with Different Methods
2002
The chemical diversity and distribution of glucosinolates and isothiocyanates among plants
2001 Standout
Myasthenia gravis
2019 Standout
Effect of Dialysis Dose and Membrane Flux in Maintenance Hemodialysis
2002 Standout
Oxidative stress in chronic kidney disease
2018 Standout
Effect of different LDL‐apheresis methods on parameters involved in atherosclerosis
2004
A Comparison of On-Line Hemodiafiltration and High-Flux Hemodialysis
2000
Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
2006 Standout
Sorbent hemoperfusion in end-stage renal disease: An in-depth review
2002
Indication of Low‐density Lipoprotein Apheresis in Severe Hypercholesterolemia and its Atherosclerotic Vascular Complications: Dextran Sulfate Cellulose Low‐density Lipoprotein Apheresis
2003
Direct Adsorption of Lipoproteins from Whole Blood by DALI Apheresis: Technique and Effects
2001
Pathogenic roles of cardiac autoantibodies in dilated cardiomyopathy
2005 StandoutNobel
Biosynthesis of glucosinolates – gene discovery and beyond
2010 Standout
Plasmapheresis and Paraproteinemia: Cryoprotein‐Induced Diseases, Monoclonal Gammopathy, Waldenström's Macroglobulinemia, Hyperviscosity Syndrome, Multiple Myeloma, Light Chain Disease, and Amyloidosis
1999
Contact Activation in Low‐density Lipoprotein Apheresis Systems
2005
How should meta‐regression analyses be undertaken and interpreted?
2002 Standout
Low-density lipoprotein apheresis as a treatment option for hyperlipidemia
2009
Variation of glucosinolate accumulation among different organs and developmental stages of Arabidopsis thaliana
2003 Standout
Principles of Separation
2013
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Membrane Plasmapheresis in the United States: A Review Over the Last 20 Years
2001
Clinical Effects of Direct Adsorption of Lipoprotein Apheresis: Beyond Cholesterol Reduction
2003
Low‐density lipoprotein apheresis reduces platelet factor 4 on the surface of platelets: a possible protective mechanism against heparin‐induced thrombocytopenia and thrombosis
2010
Adipose Tissue as an Endocrine Organ
2004 Standout
Reactive Oxygen Species Production by Monocytes and Polymorphonuclear Leukocytes During Dialysis
1991
Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis
2005 Standout
Relative in Vitro Efficacy of the Phosphate Binders Lanthanum Carbonate and Sevelamer Hydrochloride
2007 StandoutNobel
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003 Standout
A classification system for seed dormancy
2004 Standout
DALI—the first human whole‐blood low‐density lipoprotein and lipoprotein (a) apheresis system in clinical use: procedure and clinical results
1998
Surface modification with nitrogen-containing plasmas to produce hydrophilic, low-fouling membranes
2004
Surface Modifications for Antifouling Membranes
2010 Standout
Pungent products from garlic activate the sensory ion channel TRPA1
2005 StandoutNobel
Water Soluble Polymers for Pharmaceutical Applications
2011
Outline of the classification of flowering plants (magnoliophyta)
1980
Exploring Heterogeneity in Randomized Trials Via Meta-Analysis
1999
How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study
2003 Standout
Biocompatibility of hemodialysis membranes.
1990
Nutraceutical or Pharmacological Potential of Moringa oleifera Lam.
2018 Standout
Double‐Blind Evaluation of Plasmapheresis in Schizophrenic Patients: A Pilot Study
1983
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue
2013
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Calcium Phosphate Bioceramics: A Review of Their History, Structure, Properties, Coating Technologies and Biomedical Applications
2017 Standout
BIOLOGY AND BIOCHEMISTRY OF GLUCOSINOLATES
2006 Standout
Covalent interlocking of glucose oxidase and peroxidase in the voids of paper: enzyme–polymer “spider webs”
2016 StandoutNobel
Bone Grafts and Substitutes in Dentistry: A Review of Current Trends and Developments
2021 Standout
Effectiveness and efficiency of methods of dialysis therapy for end-stage renal disease: systematic reviews.
1998
Advanced functional polymer membranes
2006 Standout
Plasma exchange in the intensive care unit: Technical aspects and complications
2017
Medical applications of membranes: Drug delivery, artificial organs and tissue engineering
2007
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Coralline hydroxyapatite bone graft substitute: A review of experimental studies and biomedical applications.
2012
Maximizing the right stuff: The trade-off between membrane permeability and selectivity
2017 StandoutScience
Bone metabolism and disease in chronic kidney disease
2003
Protein adsorption on blood-contact membranes
2003
Therapeutic Plasma Exchange in Patients with Chylomicronemia Syndrome Complicated by Acute Pancreatitis
1999
Works of B. Schmidt being referenced
Lipid Apheresis by Hemoperfusion: In Vitro Efficacy and Ex Vivo Biocompatibility of a New Low‐Density Lipoprotein Adsorber Compatible with Human Whole Blood
1993
Differential Activation of Monocytes in Haemodialysis Patients Exposed to Different Types of Membranes
1990
Membranes in Artificial Organs
1996
A comparison of dialysers with low-flux membranes: significant differences in spite of many similarities
1997
LDL Hemoperfusion‐A New Procedure for LDL Apheresis: First Clinical Application of an LDL Adsorber Compatible with Human Whole Blood
1997
MECHANICAL PROPERTIES OF BONE AFTER GRAFTING WITH CORALLINE HYDROXYAPATITE: AN EXPERIMENTAL STUDY
1993
LDL Hemoperfusion‐A New Procedure for LDL Apheresis: Biocompatibility Results from a First Pilot Study in Hypercholesterolemic Atherosclerosis Patients
1997
DALI Apheresis in Hyperlipidemic Patients: Biocompatibility, Efficacy, and Selectivity of Direct Adsorption of Lipoproteins from Whole Blood
2000
Membrane plasma exchange: Principles and application techniques
1984
Biocompatibility and clinical performance of a new modified cellulose membrane.
1986
Ex vivo model of hemodialysis membrane biocompatibility.
1985
Endorphins in Schizophrenia: Hemodialysis/Hemoperfusion are Ineffective in Clearing β-Leu5-Endorphin and β-Endorphin from Human Plasma
1979
Sorbent Membrane Dialysis in Uremia1
2015
Das Vorkommen von «Myrosinase» als Hinweis auf die systematische Stellung der Batidaceae
1971
Adsorption Profile of Commercially Available Adsorbents: An in Vitro Evaluation
1992
A Clinical Study on Different Cellulosic Dialysis Membranes
1987
A comparison of Centrifugal and Membrane-based Apheresis Formats
1984
Comparative Evaluation of Filters Used in Membrane Plasmapheresis
1984
Synthetic modification of PAN membrane: biocompatibility and functional characterization
1995